InBody Co.,Ltd (KOSDAQ:041830)

South Korea flag South Korea · Delayed Price · Currency is KRW
50,900
-3,300 (-6.09%)
Jul 20, 2026, 3:30 PM KST
Market Cap679.08B +130.2%
Revenue (ttm)246.81B +16.6%
Net Income39.96B +27.5%
EPS3,115.85 +27.8%
Shares Out 13.34M
PE Ratio16.34
Forward PE14.04
Dividend600.00 (1.11%)
Ex-Dividend DateMar 30, 2026
Volume66,642
Open52,500
Previous Close54,200
Day's Range50,400 - 53,800
52-Week Range23,100 - 64,200
Beta0.66
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 342
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2025, InBody Co.,Ltd's revenue was 233.95 billion, an increase of 14.42% compared to the previous year's 204.46 billion. Earnings were 30.63 billion, a decrease of -7.57%.

Financial Statements